Filtros de búsqueda

Lista de obras de

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

scientific article published on 27 September 2019

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort

scientific article published on 17 October 2019

Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience

artículo científico publicado en 2020

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review

artículo científico publicado en 2022

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.

artículo científico publicado en 2018

Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study

scientific article published on 01 February 2020

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial

artículo científico publicado en 2014

Steroid-responsive encephalitis in Covid-19 disease

scientific article published on 17 May 2020

Steroid-responsive encephalitis in Covid-19 disease

artículo científico publicado en 2020

Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study

article

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda